Koji Nishikawa
Honkomagome, 1138677, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: May 12, 2026
Early lenvatinib dose intensity is associated with survival in super-older adults (≥80 years) with hepatocellular carcinoma: a real-world comparison with atezolizumab-bevacizumab.
Journal: European journal of gastroenterology & hepatology
Published: April 26, 2026
Non-cirrhotic portal-splenic-mesenteric vein thrombosis unmasking JAK2 V617F-positive polycythemia vera.
Journal: Clinical journal of gastroenterology
Published: December 10, 2025
Complete Response After One Cycle of Atezolizumab Plus Bevacizumab in Advanced Hepatocellular Carcinoma: Two High-Risk Contexts, Child-Pugh Class B and Advanced Age.
Journal: Cureus
Published: November 24, 2025
p16Ink4a-Positive Hepatocytes Drive Liver Fibrosis Through Activation of LIFR Family Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 10, 2025
A case of Budd-Chiari syndrome with acute venous thrombosis and liver failure: highlighting the importance of early intervention and anticoagulation therapy.
Journal: Clinical journal of gastroenterology
Published: December 06, 2024
Effectiveness of Chemotherapy on Long-Term Survival in a Case of Advanced Juvenile Hepatocellular Carcinoma Without Viral Hepatitis Infection.
Journal: Cureus
Published: January 31, 2024
A Case of Nonagenarian Gastric Anisakiasis with Atypical Presentation.
Journal: Case reports in gastroenterology
Published: January 03, 2024
Frontline evaluation: Atezolizumab-bevacizumab versus lenvatinib for BCLC stage B hepatocellular carcinoma exceeding the up-to-seven criteria.
Journal: Cancer medicine
Published: December 06, 2023
Last Updated: 09/26/2026